Tests a relapse questionnaire used by nurses for people with multiple sclerosis
Checks a phone questionnaire that helps nurses manage relapses in adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: Feasibility Study of a Relapse Investigation Questionnaire Administered by an MS Care Coordinator Nurse in Patients With Multiple Sclerosis
Key facts
- Where
- Gonesse, FranceSee the site
Where in France
- FranceGonesse, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre Hospitalier de Gonesse
- Trial code
- NCT06994026
- Record updated
- 29 May 2025
- Original description
This study aims to evaluate a questionnaire used by a specialized nurse to help manage relapses in people with multiple sclerosis (MS). The questionnaire is completed during a phone call when the patient reports new or worsening symptoms. It helps the nurse decide whether further tests or treatments are needed, based on a protocol developed with a neurologist. The goal is to improve how quickly and effectively patients receive care during a relapse. The study will include 10 adult patients with active forms of MS over a two-month period.Read full original descriptionShow less
Feasibility Study of a Relapse Investigation Questionnaire Administered by an MS Care Coordinator Nurse in Patients With Multiple Sclerosis
This study aims to evaluate a questionnaire used by a specialized nurse to help manage relapses in people with multiple sclerosis (MS). The questionnaire is completed during a phone call when the patient reports new or worsening symptoms. It helps the nurse decide whether further tests or treatments are needed, based on a protocol developed with a neurologist. The goal is to improve how quickly and effectively patients receive care during a relapse. The study will include 10 adult patients with active forms of MS over a two-month period.
Inclusion: Patients followed by Dr. Manchon for Relapsing-Remitting Multiple Sclerosis or active Secondary Progressive Multiple Sclerosis; Adult patients (aged 18 or older); Patients who have provided informed consent for participation in the local task-sharing protocol.
Exclusion: Patients with known renal failure; Minors (under 18 years old); Pregnant women; Patients who have not provided or are unable to provide consent for the local task-sharing protocol.